Discovered and developed in Australia by CSL scientists, ANDEMBRY is CSL’s first monoclonal antibody treatment; reinforces company’s commitment to providing a wide range of treatment ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback